| 1 |
Dipeptidyl peptidase 4(DPP4) inhibitors stride up the management of Parkinson's disease |
|
| | Maanvi, Shilpa Kumari, Rahul Deshmukh | | | European Journal of Pharmacology. 2022; : 175426 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Glucagon-Like Peptide-1 Receptor Agonists as Potential Myelination-Inducible and Anti-Demyelinating Remedies |
|
| | Kazunori Sango, Shizuka Takaku, Masami Tsukamoto, Naoko Niimi, Hideji Yako | | | Frontiers in Cell and Developmental Biology. 2022; 10 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases |
|
| | Yolanda Diz-Chaves, Zainab Mastoor, Carlos Spuch, Lucas C. González-Matías, Federico Mallo | | | International Journal of Molecular Sciences. 2022; 23(17): 9583 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
The Neuroprotective Effect of NEUROMIDE, a Compound Bioidentical to Commensal Bacteria Metabolites |
|
| | Yoonhee Seo, Hyunji Tak, Dohee Park, Hyejin Song, Sooyoung Choe, Chaehyeong Park, Byeongdeog Park | | | Life. 2022; 12(10): 1529 | | | [Pubmed] [Google Scholar] [DOI] | |
|
